In a clinical study, Contrave reduced about 8% of body weight in participants after 56 weeks
If you experience severe nausea, vomiting, abdominal pain, or signs of dehydration after restarting, contact your GP or diabetes team promptly rather than continuing with subsequent doses
JPMorgan's Schott said tolerability is the "key focus" for doctors, patients, and investors examining orforglipron's phase 3 data, with a goal of nausea rates below 25% and vomiting rates in the low double digits for diabetes patients
Your oral Wegovy dosing may be adjusted by your provider if you have kidney or liver conditions
A research article on the safety, compatibility and effectiveness of the glucagon receptor-GLP- 1 receptor dual agonist Survodutide in obesity management
Treatment satisfaction among participants, as assessed by both DTSQs and DTSQc [23, 24], was generally high at baseline across the seven pooled countries, but treatment with oral semaglutide significantly increased both DTSQs and DTSQc scores at the EOS: estimated mean DTSQs increased by 3.5 points and the estimated mean DTSQc score was 12.2
